STAA — STAAR Surgical Co Cashflow Statement
0.000.00%
Last trade - 00:00- $2.08bn
- $1.84bn
- $322.42m
- 85
- 12
- 55
- 49
Annual cashflow statement for STAAR Surgical Co, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2020 January 3rd | 2021 December 31st | 2021 January 1st | 2022 December 30th | 2023 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14 | 24.5 | 5.91 | 38.8 | 21.3 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 12.8 | 16.7 | 15.6 | 22.7 | 25.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.25 | -2.39 | -2.76 | -28.9 | -40.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 25.8 | 44 | 21 | 35.7 | 14.6 |
| Capital Expenditures | -10.2 | -13.6 | -8.4 | -18.1 | -18.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -138 | 92.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -10.2 | -13.6 | -8.4 | -156 | 74.3 |
| Financing Cash Flow Items | 0 | — | — | — | -2.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.149 | 17.8 | 19.6 | 8.3 | 7.42 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16 | 47.3 | 32.5 | -113 | 96.6 |